A blood test being developed by Roche to measure a marker of nerve cell damage has received CE mark approval for the detection of neuroinflammation in people with relapsing-remitting multiple sclerosis (RRMS). Called Elecsys Neurofilament Light Chain (NfL), the test is designed to measure NfL levels, which are increased in many neurological conditions due to […]
The post New blood test may help track MS disease between relapses appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com